HSBC Holdings
ADMA icon

HSBC Holdings’s ADMA Biologics ADMA Stock Holding History

HSBC Holdings’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,085
Closed -$219K – 2695
2025
Q2 		$219K Sell
12,085
-15,439
-56% -$315K ﹤0.01% 2632
2025
Q1 		$531K Sell
27,524
-2,212
-7% -$38.3K ﹤0.01% 2053
2024
Q4 		$511K Buy
29,736
+8,186
+38% +$154K ﹤0.01% 2166
2024
Q3 		$426K Sell
21,550
-23,778
-52% -$370K ﹤0.01% 2107
2024
Q2 		$500K Sell
45,328
-7,298
-14% -$61.2K ﹤0.01% 1966
2024
Q1 		$347K Buy
52,626
+19,157
+57% +$105K ﹤0.01% 2329
2023
Q4 		$153K Buy
33,469
+7,360
+28% +$27.2K ﹤0.01% 2528
2023
Q3 		$94.3K Buy
+26,109
New +$100K ﹤0.01% 2561
2023
Q1 		– Sell
-14,034
Closed -$54.5K – 2640
2022
Q4 		$54.5K Buy
+14,034
New +$43.3K ﹤0.01% 2959
2022
Q2 		– Sell
-31,968
Closed -$59K – 3215
2022
Q1 		$59K Hold
31,968
– – ﹤0.01% 3186
2021
Q4 		$45K Sell
31,968
-15
-0% -$20 ﹤0.01% 3207
2021
Q3 		$36K Sell
31,983
-1,225
-4% -$1.72K ﹤0.01% 2941
2021
Q2 		$53K Buy
33,208
+15
+0% +$26 ﹤0.01% 2886
2021
Q1 		$59K Buy
+33,193
New +$76K ﹤0.01% 2658

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HSBC Holdings's ADMA Position: Q3 2025 in Review

HSBC Holdings sold out of ADMA Biologics (ADMA) in Q3 2025, closing a stake of 12,085 shares — an estimated $219K sold.

HSBC Holdings first reported a position in ADMA in Q1 2021 and held it in 14 quarters. The position peaked at $531K in Q1 2025. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • HSBC Holdings reported no remaining ADMA Biologics position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 12,085 ADMA Biologics shares in Q3 2025, an estimated $219K.
  • HSBC Holdings first reported a position in ADMA Biologics in Q1 2021 and held it in 14 quarters.
  • HSBC Holdings's ADMA Biologics position peaked at $531K in Q1 2025.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.